✦ LIBER ✦

A phase I/II study of ofatumumab (GSK1841157) in Japanese and Korean patients with relapsed or refractory B-cell chronic lymphocytic leukemia

✍ Scribed by Yoshiaki Ogawa, Michinori Ogura, Tatsuya Suzuki…

Book ID: 120955336
Publisher: Carden Jennings Publishing
Year: 2013
Tongue: English
Weight: 275 KB
Volume: 98
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-013-1393-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum to: A phase I/II study of ofatum

Erratum to: A phase I/II study of ofatumumab (GSK1841157) in Japanese and Korean patients with relapsed or refractory B-cell chronic lymphocytic leukemia

✍ Ogawa, Yoshiaki; Ogura, Michinori; Suzuki, Tatsuya; Ando, Kiyoshi; Uchida, Toshi 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 161 KB

Bendamustine Combined With Rituximab in

Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Stilgenbauer, S.; Bahlo, J.; Schweighofer, C 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 141 KB

Phase II Study of Lenalidomide and Ritux

Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

✍ Badoux, X. C.; Keating, M. J.; Wen, S.; Wierda, W. G.; O'Brien, S. M.; Faderl, S 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 137 KB

Japanese phase II study of 90Y-ibritumom

Japanese phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma

✍ Kensei Tobinai; Takashi Watanabe; Michinori Ogura; Yasuo Morishima; Tomomitsu Ho 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Phase I study of obinutuzumab (GA101) in

Phase I study of obinutuzumab (GA101) in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma

✍ Ogura, Michinori; Tobinai, Kensei; Hatake, Kiyohiko; Uchida, Toshiki; Suzuki, Ta 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB

An open-label, pilot study of fludarabin

An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia

✍ Montillo, M.; Tedeschi, A.; Petrizzi, V. B.; Ricci, F.; Crugnola, M.; Spriano, M 📂 Article 📅 2011 🏛 American Society of Hematology 🌐 English ⚖ 147 KB